Screening for bioactive metabolites in plant extracts modulating glucose uptake and fat accumulation

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  El Houri, Rime B ^a   Kotowska, Dorota ^b   Olsen, Louise C B ^a   Bhattacharya, Sumangala ^c   Christensen, Lars P ^a   Grevsen, Kai ^c   Oksbjerg, Niels ^c   Færgeman, Nils ^a   Kristiansen, Karsten ^b   Christensen, Kathrine B ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BRASSICA OLERACEA EXTRACT; DAUCUS CAROTA EXTRACT; DICHLOROMETHANE; GLUCOSE; INSULIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; RHODIOLA ROSEA EXTRACT; SAMBUCUS NIGRA EXTRACT; SATUREJA HORTENSIS EXTRACT; THYMUS EXTRACT; UNCLASSIFIED DRUG;

3T3 CELL LINE; ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; BIOASSAY; BIOLOGICAL ACTIVITY; BRASSICA OLERACEA; CAENORHABDITIS ELEGANS; CARROT; CELL DIFFERENTIATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG IDENTIFICATION; DRUG SCREENING; FOOD; GLUCOSE BLOOD LEVEL; GLUCOSE TRANSPORT; IN VITRO STUDY; IN VIVO STUDY; LIPID STORAGE; MEDICINAL PLANT; MOUSE; MYOTUBE; NEMATODE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PLANT ROOT; PRIORITY JOURNAL; RHODIOLA ROSEA; SAMBUCUS NIGRA; SATUREJA HORTENSIS; THYME;

EID: 84929188386     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/156398     Document Type: Article

References (27)

1. R. A. DeFronzo, "The triumvirate: c-cell, muscle, liver. A collusion responsible for NIDDM," Diabetes, vol. 37, no. 6, pp. 667-687, 1988.
2. H. Yau, K. Rivera, R. Lomonaco, and K. Cusi, "The future of thiazolidinedione therapy in the management of type 2 diabetes mellitus," Current Diabetes Reports, vol. 13, no. 3, pp. 329-341, 2013.
3. A. Zieleniak, M. Wójcik, and L. A. Woźniak, "Structure and physiological functions of the human peroxisome proliferator-activated receptor c," Archivum Immunologiae et Terapiae Experimentalis, vol. 56, no. 5, pp. 331-345, 2008.
4. E. Powell, P. Kuhn, and W. Xu, "Nuclear receptor cofac-tors in PPARc-mediated adipogenesis and adipocyte energy metabolism," PPAR Research, vol. 2007, Article ID 53843, 11 pages, 2007.
5. F. Lizcano and D. Vargas, "Diverse coactivator recruitment through diferential PPARc nuclear receptor agonism," Genetics and Molecular Biology, vol. 36, no. 1, pp. 134-139, 2013.
6. E. Burgermeister, A. Schnoebelen, A. Flament et al., "A novel partial agonist of peroxisome proliferator-activated receptor-c (PPARc) recruits PPARc-coactivator-1c, prevents triglyceride accumulation, and potentiates insulin signaling in vitro," Molecular Endocrinology, vol. 20, no. 4, pp. 809-830, 2006.
7. S. Rocchi, F. Picard, J. Vamecq et al., "A unique PPARc ligand with potent insulin-sensitizing yet weak adipogenic activity," Molecular Cell, vol. 8, no. 4, pp. 737-747, 2001.
8. Y. Miyazaki, A. Mahankali, E. Wajcberg, M. Bajaj, L. J. Man-darino, and R. A. DeFronzo, "Efect of pioglitazone on cir-culating adipocytokine levels and insulin sensitivity in type 2 diabetic patients," Journal of Clinical Endocrinology and Metabolism, vol. 89, no. 9, pp. 4312-4319, 2004.
9. J. W. F. Elte and J. F. Blicklé, "Tiazolidinediones for the treatment of type 2 diabetes," European Journal of Internal Medicine, vol. 18, no. 1, pp. 18-25, 2007.
10. Y. Guan, C. Hao, D. R. Cha et al., "Tiazolidinediones expand body fuid volume through PPARc stimulation of ENaC-mediated renal salt absorption," Nature Medicine, vol. 11, no. 8, pp. 861-866, 2005.
11. J. P. Berger, A. E. Petro, K. L. Macnaul et al., "Distinct properties and advantages of a novel peroxisome proliferator-activated protein c selective modulator," Molecular Endocrinology, vol. 17, no. 4, pp. 662-676, 2003.
12. R. J. Marles and N. R. Farnsworth, "Antidiabetic plants and their active constituents," Phytomedicine, vol. 2, no. 2, pp. 137-189, 1995.
13. M. Jung, M. Park, H. C. Lee, Y. Kan, E. S. Kang, and S. K. Kim, "Antidiabetic agents from medicinal plants," Current Medicinal Chemistry, vol. 13, no. 10, pp. 1203-1218, 2006.
14. N. S. Survay, E. Y. Ko, C. P. Upadhyay et al., "Hypoglycemic efects of fruits and vegetables in hyperglycemic rats for prevention of type-2 diabetes," Korean Journal of Horticultural Science and Technology, vol. 28, no. 5, pp. 1-7, 2010.
15. H. Neef, P. Declercq, and G. Laekeman, "Hypoglycaemic activity of selected European plants," Phytotherapy Research, vol. 9, no. 1, pp. 45-48, 1995.
16. S. H. Wang, W. J. Wang, X. F. Wang, and W. H. Chen, "Efects of salidroside on carbohydrate metabolism and diferentiation of 3T3-L1 adipocytes," Journal of Chinese integrative medicine, vol. 2, no. 3, pp. 193-195, 2004.
17. M. Hotta, R. Nakata, M. Katsukawa, K. Hori, S. Takahashi, and H. Inoue, "Carvacrol, a component of thyme oil, activates PPARc and c and suppresses COX-2 expression," Journal of Lipid Research, vol. 51, no. 1, pp. 132-139, 2010.
18. K. B. Christensen, A. Minet, H. Svenstrup et al., "Identifca-tion of plant extracts with potential antidiabetic properties: efect on human peroxisome proliferator-activated receptor (PPAR), adipocyte diferentiation and insulin-stimulated glucose uptake," Phytotherapy Research, vol. 23, no. 9, pp. 1316-1325, 2009.
19. K. B. Christensen, R. K. Petersen, S. Petersen, K. Kristiansen, and L. P. Christensen, "Activation of PPARc by metabolites from the fowers of purple conefower (Echinacea purpurea)," Journal of Natural Products, vol. 72, no. 5, pp. 933-937, 2009.
20. K. B. Christensen, R. K. Petersen, K. Kristiansen, and L. P. Christensen, "Identifcation of bioactive compounds from fowers of black elder (Sambucus nigra L.) that activate the human peroxisome proliferator-activated receptor (PPAR) c," Phytotherapy Research, vol. 24, no. 2, pp. S129-S132, 2010.
21. J. B. Hansen, R. K. Petersen, B. M. Larsen, J. Bartkova, J. Alsner, and K. Kristiansen, "Activation of peroxisome proliferator-activated receptor c bypasses the function of the retinoblastoma protein in adipocyte diferentiation," The Journal of Biological Chemistry, vol. 274, no. 4, pp. 2386-2393, 1999.
22. P. K. Teil, I. L. Sørensen, P. M. Nissen, and N. Oksbjerg, "Temporal expression of growth factor genes of primary porcine satellite cells during myogenesis," Animal Science Journal, vol. 77, no. 3, pp. 330-337, 2006.
23. J. Sulston and J. Hodgkin, "Methods," in The Nematode Caen-orhabditis elegans, B. W. Wood, Ed., pp. 587-606, Cold Spring Harbor Laboratory Press, New York, NY, USA, 1988.
24. T. Stiernagle, "Maintenance of C. elegans," in The C. elegans Research Community, WormBook, 2006, http://www.worm-book.org/.
25. P. E. Kuwabara and N. O'Neil, "The use of functional genomics in C. elegans for studying human development and disease," Journal of Inherited Metabolic Disease, vol. 24, no. 2, pp. 127-138, 2001.
26. P. Tejass and G. Kuttan, "Augmentation of natural killer cell and antibody-dependent cellular cytotoxicity in BALB/c mice by sulforaphane, a naturally occurring isothiocyanate from broccoli through enhanced production of cytokines IL-2 and IFN-c," Immunopharmacology and Immunotoxicology, vol. 28, no. 3, pp. 443-457, 2006.
27. V. Rozman, I. Kalinovic, and Z. Korunic, "Toxicity of naturally occurring compounds of Lamiaceae and Lauraceae to three stored-product insects," Journal of Stored Products Research, vol. 43, no. 4, pp. 349-355, 2007.